Weekly combination of oxaliplatin (OX) and irinotecan (IRI) in 5-FU resistant colorectal cancer (CRC)

✍ Scribed by Kretzschmar, A.; Thuss-Patience, P.C.; Pink, D.; Grothey, A.; Schmoll, H.J.; Oettle, H.; Scholz, C.; Dörken, B.; Reichardt, P.

• Book ID: 123045524
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 197 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81566-5